Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

Intercept Pharmaceuticals to Participate in Piper Sandler’s 34th Annual Healthcare Conference on December 1, 2022 
By: GlobenewsWire - 22 Nov 2022Back to overview list

MORRISTOWN, N.J., Nov. 22, 2022 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, today announced that Jerry Durso, President and Chief Executive Officer of Intercept, and Andrew Saik, Chief Financial Officer of Intercept, will participate in a fireside chat at Piper Sandler’s 34th Annual Healthcare Conference, taking place in person on Thursday, December 1, 2022. The Company will also conduct meetings with investors.

Intercept's fireside chat will take place from 2:00 p.m. – 2:25 p.m. ET. To view the fireside chat, please register for the Piper Sandler 34th Annual Healthcare Conference by contacting your representative. Investors attending the conference who wish to meet with the Intercept management team, please reach out to your representative or contact Nareg Sagherian

About Intercept 
Intercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, including primary biliary cholangitis (PBC), nonalcoholic steatohepatitis (NASH) and severe alcohol-associated hepatitis (sAH). For more information, please visit?www.interceptpharma.com?or connect with the Company on Twitter and LinkedIn. 

Contact 
For more information about Intercept, please contact: 

Investor inquiries:?investors@interceptpharma.com 
Media inquiries:?media@interceptpharma.com 


Related companies:Intercept Pharmaceuticals Inc.
Copyright 2022 GlobenewsWire Back to overview list
to the top ↑
{literal} {/literal}